Uses AI to: Process raw phenotypic, imaging, drug, and genomic data sets. Allows researchers to: Integrate rapid analytics and machine learning capabilities into existing business processes to improve care, enhance discoveries, gain insight into business, and enable fast data-driven decisions.
Market Analysis and Insights: Global Artificial Intelligence (AI) in Drug Discovery Market
The global Artificial Intelligence (AI) in Drug Discovery market is projected to grow from US$ 950.6 million in 2024 to US$ 3210.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 22.5% during the forecast period.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Artificial Intelligence (AI) in Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artificial Intelligence (AI) in Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence (AI) in Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Intelligence (AI) in Drug Discovery revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Intelligence (AI) in Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Artificial Intelligence (AI) in Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
IBM
Microsoft
Google
NVIDIA Corporation
Atomwise, Inc.
Deep Genomics
Cloud Pharmaceuticals
Insilico Medicine
BenevolentAI
Exscientia
Cyclica
BIOAGE
Numerate
NuMedii
Envisagenics
twoXAR
OWKIN, Inc.
XtalPi
Verge Genomics
BERG LLC
Segment by Type
Software
Services
Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers and Academic & Government Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Intelligence (AI) in Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Drug Discovery companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence (AI) in Drug Discovery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Drug Discovery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Services
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Drug Discovery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Research Organizations
1.3.4 Research Centers and Academic & Government Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Drug Discovery Market Perspective (2019-2030)
2.2 Global Artificial Intelligence (AI) in Drug Discovery Growth Trends by Region
2.2.1 Artificial Intelligence (AI) in Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence (AI) in Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence (AI) in Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence (AI) in Drug Discovery Market Dynamics
2.3.1 Artificial Intelligence (AI) in Drug Discovery Industry Trends
2.3.2 Artificial Intelligence (AI) in Drug Discovery Market Drivers
2.3.3 Artificial Intelligence (AI) in Drug Discovery Market Challenges
2.3.4 Artificial Intelligence (AI) in Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artificial Intelligence (AI) in Drug Discovery by Players
3.1.1 Global Artificial Intelligence (AI) in Drug Discovery Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence (AI) in Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence (AI) in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Intelligence (AI) in Drug Discovery, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Artificial Intelligence (AI) in Drug Discovery Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Drug Discovery Revenue in 2023
3.5 Global Key Players of Artificial Intelligence (AI) in Drug Discovery Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Drug Discovery, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Drug Discovery Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence (AI) in Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence (AI) in Drug Discovery Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence (AI) in Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence (AI) in Drug Discovery Market Size (2019-2030)
6.2 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Type
6.2.1 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2019-2024)
6.2.2 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2025-2030)
6.2.3 North America Artificial Intelligence (AI) in Drug Discovery Market Share by Type (2019-2030)
6.3 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Application
6.3.1 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2019-2024)
6.3.2 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2025-2030)
6.3.3 North America Artificial Intelligence (AI) in Drug Discovery Market Share by Application (2019-2030)
6.4 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Country
6.4.1 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Country (2019-2024)
6.4.3 North America Artificial Intelligence (AI) in Drug Discovery Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Size (2019-2030)
7.2 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Type
7.2.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2019-2024)
7.2.2 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2025-2030)
7.2.3 Europe Artificial Intelligence (AI) in Drug Discovery Market Share by Type (2019-2030)
7.3 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Application
7.3.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2019-2024)
7.3.2 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2025-2030)
7.3.3 Europe Artificial Intelligence (AI) in Drug Discovery Market Share by Application (2019-2030)
7.4 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Country
7.4.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Country (2019-2024)
7.4.3 Europe Artificial Intelligence (AI) in Drug Discovery Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artificial Intelligence (AI) in Drug Discovery Market Size (2019-2030)
8.2 China Artificial Intelligence (AI) in Drug Discovery Market Size by Type
8.2.1 China Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2019-2024)
8.2.2 China Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2025-2030)
8.2.3 China Artificial Intelligence (AI) in Drug Discovery Market Share by Type (2019-2030)
8.3 China Artificial Intelligence (AI) in Drug Discovery Market Size by Application
8.3.1 China Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2019-2024)
8.3.2 China Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2025-2030)
8.3.3 China Artificial Intelligence (AI) in Drug Discovery Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Artificial Intelligence (AI) in Drug Discovery Market Size (2019-2030)
9.2 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Type
9.2.1 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2019-2024)
9.2.2 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2025-2030)
9.2.3 Asia Artificial Intelligence (AI) in Drug Discovery Market Share by Type (2019-2030)
9.3 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Application
9.3.1 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2019-2024)
9.3.2 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2025-2030)
9.3.3 Asia Artificial Intelligence (AI) in Drug Discovery Market Share by Application (2019-2030)
9.4 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Region
9.4.1 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Region (2019-2024)
9.4.3 Asia Artificial Intelligence (AI) in Drug Discovery Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Drug Discovery Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Drug Discovery Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.1.5 IBM Recent Developments
11.2 Microsoft
11.2.1 Microsoft Company Details
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Drug Discovery Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.2.5 Microsoft Recent Developments
11.3 Google
11.3.1 Google Company Details
11.3.2 Google Business Overview
11.3.3 Google Artificial Intelligence (AI) in Drug Discovery Introduction
11.3.4 Google Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.3.5 Google Recent Developments
11.4 NVIDIA Corporation
11.4.1 NVIDIA Corporation Company Details
11.4.2 NVIDIA Corporation Business Overview
11.4.3 NVIDIA Corporation Artificial Intelligence (AI) in Drug Discovery Introduction
11.4.4 NVIDIA Corporation Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.4.5 NVIDIA Corporation Recent Developments
11.5 Atomwise, Inc.
11.5.1 Atomwise, Inc. Company Details
11.5.2 Atomwise, Inc. Business Overview
11.5.3 Atomwise, Inc. Artificial Intelligence (AI) in Drug Discovery Introduction
11.5.4 Atomwise, Inc. Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.5.5 Atomwise, Inc. Recent Developments
11.6 Deep Genomics
11.6.1 Deep Genomics Company Details
11.6.2 Deep Genomics Business Overview
11.6.3 Deep Genomics Artificial Intelligence (AI) in Drug Discovery Introduction
11.6.4 Deep Genomics Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.6.5 Deep Genomics Recent Developments
11.7 Cloud Pharmaceuticals
11.7.1 Cloud Pharmaceuticals Company Details
11.7.2 Cloud Pharmaceuticals Business Overview
11.7.3 Cloud Pharmaceuticals Artificial Intelligence (AI) in Drug Discovery Introduction
11.7.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.7.5 Cloud Pharmaceuticals Recent Developments
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence (AI) in Drug Discovery Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.8.5 Insilico Medicine Recent Developments
11.9 BenevolentAI
11.9.1 BenevolentAI Company Details
11.9.2 BenevolentAI Business Overview
11.9.3 BenevolentAI Artificial Intelligence (AI) in Drug Discovery Introduction
11.9.4 BenevolentAI Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.9.5 BenevolentAI Recent Developments
11.10 Exscientia
11.10.1 Exscientia Company Details
11.10.2 Exscientia Business Overview
11.10.3 Exscientia Artificial Intelligence (AI) in Drug Discovery Introduction
11.10.4 Exscientia Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.10.5 Exscientia Recent Developments
11.11 Cyclica
11.11.1 Cyclica Company Details
11.11.2 Cyclica Business Overview
11.11.3 Cyclica Artificial Intelligence (AI) in Drug Discovery Introduction
11.11.4 Cyclica Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.11.5 Cyclica Recent Developments
11.12 BIOAGE
11.12.1 BIOAGE Company Details
11.12.2 BIOAGE Business Overview
11.12.3 BIOAGE Artificial Intelligence (AI) in Drug Discovery Introduction
11.12.4 BIOAGE Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.12.5 BIOAGE Recent Developments
11.13 Numerate
11.13.1 Numerate Company Details
11.13.2 Numerate Business Overview
11.13.3 Numerate Artificial Intelligence (AI) in Drug Discovery Introduction
11.13.4 Numerate Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.13.5 Numerate Recent Developments
11.14 NuMedii
11.14.1 NuMedii Company Details
11.14.2 NuMedii Business Overview
11.14.3 NuMedii Artificial Intelligence (AI) in Drug Discovery Introduction
11.14.4 NuMedii Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.14.5 NuMedii Recent Developments
11.15 Envisagenics
11.15.1 Envisagenics Company Details
11.15.2 Envisagenics Business Overview
11.15.3 Envisagenics Artificial Intelligence (AI) in Drug Discovery Introduction
11.15.4 Envisagenics Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.15.5 Envisagenics Recent Developments
11.16 twoXAR
11.16.1 twoXAR Company Details
11.16.2 twoXAR Business Overview
11.16.3 twoXAR Artificial Intelligence (AI) in Drug Discovery Introduction
11.16.4 twoXAR Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.16.5 twoXAR Recent Developments
11.17 OWKIN, Inc.
11.17.1 OWKIN, Inc. Company Details
11.17.2 OWKIN, Inc. Business Overview
11.17.3 OWKIN, Inc. Artificial Intelligence (AI) in Drug Discovery Introduction
11.17.4 OWKIN, Inc. Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.17.5 OWKIN, Inc. Recent Developments
11.18 XtalPi
11.18.1 XtalPi Company Details
11.18.2 XtalPi Business Overview
11.18.3 XtalPi Artificial Intelligence (AI) in Drug Discovery Introduction
11.18.4 XtalPi Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.18.5 XtalPi Recent Developments
11.19 Verge Genomics
11.19.1 Verge Genomics Company Details
11.19.2 Verge Genomics Business Overview
11.19.3 Verge Genomics Artificial Intelligence (AI) in Drug Discovery Introduction
11.19.4 Verge Genomics Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.19.5 Verge Genomics Recent Developments
11.20 BERG LLC
11.20.1 BERG LLC Company Details
11.20.2 BERG LLC Business Overview
11.20.3 BERG LLC Artificial Intelligence (AI) in Drug Discovery Introduction
11.20.4 BERG LLC Revenue in Artificial Intelligence (AI) in Drug Discovery Business (2019-2024)
11.20.5 BERG LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
IBM
Microsoft
Google
NVIDIA Corporation
Atomwise, Inc.
Deep Genomics
Cloud Pharmaceuticals
Insilico Medicine
BenevolentAI
Exscientia
Cyclica
BIOAGE
Numerate
NuMedii
Envisagenics
twoXAR
OWKIN, Inc.
XtalPi
Verge Genomics
BERG LLC
听
听
*If Applicable.
